Aethlon Medical (AEMD) Cash & Equivalents (2010 - 2026)

Aethlon Medical's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $5.0 million for Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 8.63% year-over-year to $5.0 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (down 8.63% YoY), and the FY2026 full-year result was $5.0 million, down 8.63% from the prior year.
• Cash & Equivalents was $5.0 million for Q1 2026 at Aethlon Medical, down from $7.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for AEMD reached as high as $19.7 million in Q3 2022 and fell as low as $3.9 million in Q2 2025.
• Median Cash & Equivalents over the past 5 years was $8.1 million (2023), compared with a mean of $9.9 million.
• Across the five-year window, Cash & Equivalents soared 73.19% in 2022 and sank 62.18% in 2024, its largest moves.
• Over 5 years, Cash & Equivalents stood at $17.6 million in 2022, then tumbled by 54.17% to $8.1 million in 2023, then slumped by 39.04% to $4.9 million in 2024, then soared by 43.6% to $7.1 million in 2025, then slipped by 28.75% to $5.0 million in 2026.
• Business Quant data shows AEMD's Cash & Equivalents at $5.0 million in Q1 2026, $7.1 million in Q4 2025, and $6.0 million in Q3 2025.